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Cardiovascular disease (CVD) remains the world’s leading cause of death. Predicting the occurrence of future CVD in apparently healthy asymptomatic subjects remains a major challenge in contemporary cardiovascular medicine. Age is a highly predictive risk factor for future CVD  ADDIN EN.CITE (; ). Several studies have reported that advancing age is associated with increased incidence of coronary heart disease, stroke and heart failure (). Consequently, the use of chronological age is of great importance in the prediction of CVD  ADDIN EN.CITE (; ; ). However, the mechanisms through which older age affects future development of CVD are not fully understood and the extent to which chronological age provides a surrogate for biological age of the vasculature remains obscure. In this review, we pose a number of questions to better understand the impact of chronological and biological age on the development of CVD in humans. 

Can we successfully predict cardiovascular events? 	
Several traditional and novel CV risk factors independently predict the future development of CVD  ADDIN EN.CITE (; ; ; ) and the combination of some of these risk factors predict future events. For example, the Framingham Risk Score (FRS) uses an algorithm, involving traditional CV risk factors like age, cholesterol, HDL, sex, smoking and systolic blood pressure to calculate the 10-yr prediction of a CV event  ADDIN EN.CITE (; ; ). A systematic review showed that the sensitivity and specificity of the FRS for future CV events, based on the area under the receiver operator curve, ranged between 0.60-0.86 (). This indicates that traditional CV risk factors fail to predict future CVD in a large proportion of cases (up to 50%)  ADDIN EN.CITE (). To support this view, traditional CV risk factors are poorly related to coronary atherosclerotic plaque burden  ADDIN EN.CITE (). Moreover, the observation of a receiver operator curve of only 0.53 in an older cohort of ~85 years () suggests that older age affects the ability of the FRS to predict future CVD using risk factors. The inability to accurately predict future events in individual patients is not specific for a single algorithm, since poor agreement is observed between multiple risk calculators when allocating subjects to risk categories (). Taken together, the relative impact or importance of CV risk factors may differ between populations. 

Traditionally, the impact of age on CV risk has been ascribed to the time-dependent accumulation of harmful CV risk factors (). Nonetheless, older age predicts future CVD independently of other risk factors  ADDIN EN.CITE (; ), raising the question of direct impacts of ageing per se. Possibly, changes in the structure and function of the vasculature may directly explain age-related changes in CV risk. 

What is the impact of older age on vascular function? 
Studies that examined the impact of age on vascular function have typically adopted a cross-sectional design, whereby healthy volunteers with a substantial age range were tested. Studies investigating coronary artery peak blood flow response to intracoronary infusion of acetylcholine, an endothelium-dependent dilator, demonstrate a progressive decline of the maximal response with age  ADDIN EN.CITE (). Comparable observations can be made when examining coronary artery dilator responses to other vasoactive substances and/or manipulations  ADDIN EN.CITE ().
 
In peripheral vessels, measurement of conduit artery endothelial function using flow mediated dilation (FMD), also demonstrates a progressive decline with age (). The age-related impairment in conduit artery endothelial function has been reported in the brachial  ADDIN EN.CITE (; ; ), femoral () and popliteal  ADDIN EN.CITE () arteries. The onset of the age-related decline in conduit artery endothelial function is reported to occur at an earlier stage in males than females (). However, females may exhibit accelerated functional descent after the onset of decline (). Similar observations of an age-related, gradual decline in endothelial function can be observed when examining forearm resistance artery function by intra-arterial infusion of acetylcholine  ADDIN EN.CITE (; ; ) and methacholine chloride (). Finally, measures of endothelial function in the cutaneous microcirculation provide evidence that older age leads to an impaired microvascular dilation response to local  ADDIN EN.CITE (; ) and systemic  ADDIN EN.CITE () heating, but also to local infusion of acetylcholine  ADDIN EN.CITE (; ). 

Taken together, these studies demonstrate a gradual, age-related decline in vascular function that occurs throughout the vascular tree, ranging from coronary arteries to peripheral conduit, resistance and microvessels in humans. These conclusions are supported by studies that adopt alternative measures of vascular function, such as measures of arterial compliance and stiffness (see later section  ADDIN EN.CITE (; )).

Why is vascular function impaired with older age? 
Given the potent anti-atherogenic properties of nitric oxide (NO), many studies have explored the role of this vasodilator pathway in explaining age-related loss of vascular function. Some studies have indicated that older age is associated with diminished forearm vasoconstrictor response to infusion of NO-synthase inhibitor NG-monomethyl-L-Arginine (L-NMMA), suggesting reduced NO bioavailability in resistance arteries  ADDIN EN.CITE (; ). Moreover, in older adults, supplementation of L-arginine, the pre-cursor for NO, improves skin blood flow responses to whole body heating  ADDIN EN.CITE () and coronary artery blood flow response to acetylcholine (). NO mediates a significant component of the FMD-response  ADDIN EN.CITE (); a measure that is typically reduced with older age. Age-related decreases in tetrahydrobiopterin (BH4) synthesis, an important co-factor in NO production, provides further support for the presence of impairment of the NO-pathway with older age (). Indeed, BH4-supplementation in older humans enhanced brachial artery FMD  ADDIN EN.CITE () as well as the NO-dependent dilation of forearm blood flow responses to acetylcholine  ADDIN EN.CITE (). Although previous reports have consistently reported the presence of lower NO bioavailability, somewhat conflicting results have been reported regarding eNOS expression in vascular endothelial cells in older humans  ADDIN EN.CITE (; ).

In addition to this focus on impaired vasodilator mechanisms, some studies have explored the impact of older age on vasoconstrictor pathways, in particular endothelin-1 (ET-1). For example, older men exhibit a greater lower limb vasodilation response to ET-receptor blockade, indicative for a greater contribution of ET-1 to vascular tone with age  ADDIN EN.CITE (). Comparable results were reported for the forearm resistance vascular bed, as older men demonstrate a bunted forearm blood flow response to exogenous ET-1  ADDIN EN.CITE (). It was also demonstrated that an increased ET-1 expression in older men was inversely related to endothelial dependent dilation  ADDIN EN.CITE (). Mechanistically, these changes in the contribution of ET-1 may relate to changes in sensitivity (and/or density) of ETA-receptors (causing vasoconstriction) and/or ETB-receptors (leading to vasodilation). Previous work in animals demonstrated that the augmented vasoconstrictor response to ET-1 in older rats is mediated through an increased ETA-pathway  ADDIN EN.CITE (), whilst other work provided evidence for impairment in the ETB-receptors  ADDIN EN.CITE (). Impaired ETB-receptors may also contribute to higher ET-1 plasma levels since these receptors contribute to ET-1 clearance. Future work is needed to confirm these hypotheses.  

In addition to an (age-related) altered endogenous bioavailability of vasoactive substances, impaired vascular function with age may also relate to changes in smooth muscle function. Ultimately, (magnitude of) dilation or constriction of vessels depends on the ability of the smooth muscle cells to alter tone. The capacity of conduit and resistance artery smooth muscle cells to dilate is typically assessed as the dilatory response following sublingual nitroglycerine (GTN) or intra-arterial infusion of sodium nitroprusside (SNP), respectively. A recent meta-analysis demonstrated a small but significant age-related impairment in smooth muscle function in conduit and resistance arteries  ADDIN EN.CITE (). These findings suggest that the age-related impairment in vascular function may, at least partly, be explained by attenuated smooth muscle cell function.  A potential mechanistic explanation for this finding may relate to decreased expression of soluble guanylyl cyclase on smooth muscle cells (sGC; the principal receptor of NO and mediating dilation), such as observed in older animals  ADDIN EN.CITE (; ).

The mechanisms underlying age-associated vascular dysfunction may relate to increased vascular oxidative stress and inflammation with older age, leading to pro-inflammatory phenotypical changes. In men, ageing is associated with increased endothelial cell oxidative stress and markers of inflammation, both of which are related to the age-related impairment in endothelial function  ADDIN EN.CITE (; ). Studies in older humans have found increased levels of inflammatory proteins, such as pro-inflammatory nuclear factor-κB and cytokines (e.g. IL-6, TNF-α, MCP-1)  ADDIN EN.CITE (; ). A potential role for inflammation in age-related changes in vascular function is provided by the finding that inhibition of nuclear factor-κB improves brachial artery endothelial function in older individuals  ADDIN EN.CITE (; ). Support for a role of vascular oxidative stress is provided by studies reporting that older humans demonstrate increased markers of oxidative stress (e.g. nitrotyrosine)  ADDIN EN.CITE (), whilst this marker is inversely related with endothelial function  ADDIN EN.CITE (). Furthermore, infusion of ascorbic acid (i.e. a reactive oxygen species scavenger) attenuated the impairment in brachial artery FMD  ADDIN EN.CITE () and increased acetylcholine-induced vasodilation of the forearm vessels in older adults  ADDIN EN.CITE (). The mechanism of increased oxidative stress with older age may relate to elevated levels of reactive oxygen species combined with reduced (or absent compensatory improvements in) antioxidative capacity  ADDIN EN.CITE (). These data suggest that older age is associated with increased oxidative stress and inflammation that, subsequently, may contribute to the impaired vascular function typically observed in older humans (Figure 1). 

Why is vascular function impaired with older age: molecular pathways? 
Pathways underlying the development of vascular dysfunction may relate to those involved in senescence (), that is irreversible cell cycle arrest as a result of critically short telomeres or external stress (e.g. oxidative stress, DNA damage), possibly through the p53/p21 pathway  ADDIN EN.CITE (; ). Senescent cells demonstrate an increased rate of apoptosis, impaired proliferation, eNOS inhibition and increases in mediators for inflammation  ADDIN EN.CITE (; ). Accumulation of senescent cells have been reported in atherosclerotic lesions (). 

Sirtuins, originally linked to metabolic health, may represent an important molecular regulator of vascular ageing  ADDIN EN.CITE (; ). For example, expression of SIRT1 (through p51 and p66Shc) has been linked with protection against oxidative stress-induced cellular senescence/apoptosis, improved NO bioavailability and lower inflammation  ADDIN EN.CITE (; ). Nonetheless, the role of sirtuins in mediating age-related cardiovascular changes is under debate. Other molecular pathways, such as microRNAs and endothelial progenitor cells, may also contribute to the cellular changes with older age. Future studies should explore the potential role of (novel) molecular pathways related to (accelerated) cellular senescence. 

What is the impact of older age on vascular structure: wall thickness? 
When exploring the impact of older age on the structure of arteries, a common and frequently reported observation is the age-related increase in carotid artery intima-media thickness (IMT)  ADDIN EN.CITE (; ; ; ) (Figure 1). The increase in carotid IMT occurs linearly (~5 µm/year) with older age, in both men and women  ADDIN EN.CITE (; ). Increased blood pressure, by virtue of exerting a greater distending force on the arterial walls, is suggested to importantly contribute to carotid artery thickening  ADDIN EN.CITE (). To further support this link, 9-month anti-hypertensive treatment significantly decreased carotid IMT, with the magnitude of decrease in IMT being closely related to the decrease in carotid pulse pressure  ADDIN EN.CITE ().

Despite the strong scientific focus on the carotid artery, thickening of the arterial wall with age is also observed in upper and lower limb peripheral vessels  ADDIN EN.CITE (; ; ). Moreover, the magnitude of age-related thickening seems comparable between central and peripheral arteries (). This is of particular importance, since the brachial artery is not considered atherosclerosis-prone (), suggesting that thickening of the conduit arterial wall represents a systemic effect of ageing per se (). To further support a common pathway for arterial thickening, systolic blood pressure (and therefore distending pressure) is positively correlated to brachial, superficial femoral and popliteal IMT (), a finding similar to that observed for the carotid artery  ADDIN EN.CITE ().

What is the impact of older age on vascular structure: diameter? 
Conduit artery diameter demonstrates a gradual increase with age in both central  ADDIN EN.CITE (; ) and peripheral  ADDIN EN.CITE (; ; ; ; ) vessels (Figure 1). In fact, the relative increase in diameter with older age is comparable between central and (lower and upper limb) peripheral vessels (). Cross sectional analysis of the common carotid artery demonstrates a 0.017 mm/year increase in those without atherosclerosis, while a 0.03 mm/year increase is observed in those with pre-existing disease  ADDIN EN.CITE (). In lower limb vessels, popliteal and femoral diameter increases between 22-26% and 12-21% across a ~40 year age span (25-67 years), equivalent to a ~0.5% increase in diameter per year, despite maintenance of a constant body surface area  ADDIN EN.CITE (; ). 

The mechanisms behind the age-related increase in diameter are unclear. It is suggested that lumen enlargement is a compensatory adaptation to plaque formation and/or increases in wall thickness, in order to maintain luminal area. Whilst evidence supports the presence of this adaptation in the carotid  ADDIN EN.CITE (; ) and peripheral  ADDIN EN.CITE () vasculature, enlargement of lumen diameters can occur in the absence of plaque formation  ADDIN EN.CITE (; ), suggesting a compensatory enlargement cannot fully explain the increase in diameter with age. Alternatively, dilation may occur due to age-related loss of elastic fibres  ADDIN EN.CITE (), fracturing of the elastic lamellae  ADDIN EN.CITE (), and/or as an adaptation to stiffening of the vasculature  ADDIN EN.CITE (). Especially the age-related loss of elastin may be of particular importance in the observed changes in diameter. With older age, elastin content decreases, elastin elongates and loses some of the elastic recoil properties (). Consequently, arteries rely more on the stiffer collagen in the arterial wall and become somewhat larger. 

What is the impact of older age on vascular structure: arterial stiffness? 
Early studies demonstrated the impact of older age on pulse wave velocity (a measure reflecting stiffness of the arterial system) (). Subsequent large-scale studies (e.g. Atherosclerosis Risk In Communities, Baltimore Longitudinal Study of Aging) reinforced the observation that older age is independently related to an increase in pulse wave velocity  ADDIN EN.CITE (; ). Interestingly, a steeper age-related increase in pulse wave velocity may be present in men compared to women  ADDIN EN.CITE () and/or in the presence of CV risk factors.

The age-related increase in stiffness of (large and smaller-sized) vessels likely result from mechanical factors such as pressure, but also from pressure-independent factors (). Recent studies have suggested a potential role for age-related increases in the formation of advanced glycation end-products (AGEs) in the arterial wall that may contribute to vascular dysfunction (). AGEs represent the end-product of a non-enzymatic reaction with sugar derivates that lead to irreversible crosslinks with proteins (). In the arterial wall, AGEs can bind to collagen, leading to changes in the mechanical properties of the vascular wall. However, the exact importance of these glycation end-products on arterial stiffness and function remains somewhat unclear  ADDIN EN.CITE (). 

Is there an interaction between vascular function and structure? 
Vascular function and structure are often examined as independent characteristics. However, previous work has repeatedly demonstrated that conduit artery diameter is inversely correlated with vasodilator function  ADDIN EN.CITE (; ; ). Whilst frequently reported for the brachial artery, the strong relation between diameter and dilator response is similarly present in different sized and located arteries and the relation remains present after correcting for the shear rate stimulus  ADDIN EN.CITE (). The larger dilator response in smaller vessels may result from structural characteristics, since smaller vessels have more smooth muscle relative to elastic laminae, resulting in a larger wall-to-lumen ratio. Supporting this hypothesis, a positive relation was observed between wall-to-lumen ratio and endothelium-dependent and –independent vasodilator responses of upper and lower limb vessels  ADDIN EN.CITE (). The presence of hyper-responsiveness in vessels with increased wall-to-lumen aligns with work of Folkow who, as early as in 1955, calculated that increased wall-to-lumen ratio would enhance vasodilator responsiveness (). Whilst the strong interaction between vascular function and structure is well-established, the impact of the ageing process on this relationship is an area for future investigation. 

Do measures of vascular function or structure predict future CV events? 
Earlier sections have clearly demonstrated that older age, independent of other CV risk factors, can impact measures of vascular function and structure. Here, we summarise data to better understand whether changes in these vascular characteristics relate to changes in CV risk. Generally, studies have found evidence that measures of endothelial function are strongly related to the future development of CV events. For example, assessment of coronary artery function, either in response to intra-arterial infusion of drugs or in response to a sympathetic stimulus, is predictive for future CVD  ADDIN EN.CITE (; ). Moreover, the predictive value of the coronary artery dilator response to intra-coronary infusion of acetylcholine is independent of traditional CV risk factors  ADDIN EN.CITE (). Other measures of the peripheral vasculature, such as central or peripheral vascular stiffness, also demonstrate independent predictive capacity for future CV events (). For example, a 1 m/s increase in aortic pulse wave velocity was related to an age, sex and risk factor adjusted risk elevation of 14%, 15% and 15% for total CV events, CV mortality and all-cause mortality respectively (). Even measurements of skin microvessel function correlate with FRS, with impaired microvascular function being related to increased CV risk  ADDIN EN.CITE (; ).

Given the relatively simple procedures, several studies have examined the predictive capacity of the brachial artery FMD and have shown, both in asymptomatic and symptomatic subjects, FMD can predict future CV events  ADDIN EN.CITE (; ; ; ; ). Importantly, these studies have typically found that the predictive capacity of the brachial artery FMD is independent of other CV risk factors. Combining brachial FMD with the FRS enhanced CV risk classification compared to the FRS in isolation (). However, the predictive capacity of the FMD may be reduced in older populations  ADDIN EN.CITE (). Age-related stiffening of the arteries and increases in diameter, and consequently attenuated dilator capacity, may contribute to these findings. In fact, the same authors found that brachial artery diameter (but not FMD) demonstrates independent predictive value for future CV events in older adults  ADDIN EN.CITE (). 

Regarding other structural aspects of conduit arteries, studies have demonstrated that thickening of the arterial wall of carotid and peripheral vessels are both strong independent predictors of future CVD. A large number of studies have demonstrated that increased carotid  ADDIN EN.CITE (; ; ; ) and peripheral artery  ADDIN EN.CITE () IMT is independently associated with future CV events. Specifically for carotid artery IMT, a meta-analysis showed that a 0.1 mm increase in IMT is associated with an increase in relative risk for myocardial infarction of 10-15% (). Taken together, data provide strong evidence that functional and structural characteristics of peripheral and central arteries are strongly related to future CV events in humans. 

Vascular health to distinguish biological versus chronological age of arteries?
There is strong evidence that older age leads to a gradual change in vascular function and structure in several arterial beds, by various measures of function. This may explain why chronological age is strongly and independently related to CV risk. However, this does not necessarily inform us about the biological age of vessels. Repeated exposure to potentially harmful stimuli across the lifespan can ultimately lead to between-subject differences in vascular function, structure and health, with consequential dissociation between biological and chronological age. These differences may, in part, relate to inter-individual differences in susceptibility for vascular adaptations and/or atherosclerosis. An integrative measure of vascular structure and function, scaled for chronological age, could conceivably provide better prediction of the true biological age of human arteries.

Conclusion
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FIGURE 1. Schematic presentation of an endothelial cell and smooth muscle cell (top panel; including the most important pathways involved in the regulation of endothelial function) and structural aspects of an artery (lower panel; lumen size and wall thickness) in healthy young (left side) and older humans (right side). The difference in size of the various symbols between young and older humans relate to the impact of older age. 




